arrow_back Back to App

Glioblastoma Awareness Day: Boosting Research and Support for Patients.

The U.S. Senate designated July 19, 2023, as Glioblastoma Awareness Day to highlight this aggressive brain cancer. The resolution aims to increase public knowledge, honor patients and caregivers, and encourage greater investment in research for new treatments. This action supports research initiatives and potentially accelerates the development of life-saving therapies for those affected.
Key points
Designates July 19 as Glioblastoma Awareness Day to increase public understanding of this deadly brain tumor.
Supports increased funding and collaborative research efforts, including the Glioblastoma Therapeutics Network (GTN).
Honors patients and caregivers and recognizes the critical role of molecular biomarker testing in diagnosis and treatment.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_257
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2023-06-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating July 19, 2023, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_257.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-06-15.

What are the main provisions?

Key points include:

  • Designates July 19 as Glioblastoma Awareness Day to increase public understanding of this deadly brain tumor.
  • Supports increased funding and collaborative research efforts, including the Glioblastoma Therapeutics Network (GTN).
  • Honors patients and caregivers and recognizes the critical role of molecular biomarker testing in diagnosis and treatment.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2127-2128; text: CR S2127)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health